INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Scope & Guideline
Exploring breakthroughs in infectious disease management.
Introduction
Aims and Scopes
- Epidemiology and Public Health:
The journal consistently emphasizes the epidemiological aspects of infectious diseases, including prevalence, incidence, and demographic factors influencing disease spread and outcomes. - Clinical Research and Treatment Outcomes:
A significant portion of published research focuses on clinical trials, treatment efficacy, and management strategies for various infectious diseases, highlighting outcomes in diverse patient populations. - Vaccine Development and Immunization Strategies:
The journal features studies on vaccine efficacy, immunogenicity, and the public health implications of vaccination programs, especially in the context of emerging infectious diseases. - Antimicrobial Resistance:
Research addressing the growing concern of antimicrobial resistance, including surveillance, resistance mechanisms, and strategies to combat resistant infections, is a recurrent theme. - Infectious Disease Pathogenesis and Microbiology:
The journal publishes studies on the microbiological aspects and pathogenesis of infectious diseases, providing insights into the underlying mechanisms of infection and disease progression. - Global Health Perspectives:
The journal includes articles that explore infectious disease challenges in low- and middle-income countries, emphasizing the importance of equitable health solutions and global health security.
Trending and Emerging
- COVID-19 Research:
A significant trend is the extensive research related to COVID-19, encompassing virology, epidemiology, treatment efficacy, vaccine development, and long-term effects of infection. - Mental Health and Infectious Diseases:
There is an emerging focus on the mental health implications of infectious disease outbreaks, particularly in relation to the psychological impact of the COVID-19 pandemic on various populations. - One Health Approach:
The journal increasingly features studies applying the One Health framework, which integrates human, animal, and environmental health to address infectious disease threats comprehensively. - Telemedicine and Remote Care:
Research on the role of telemedicine and digital health solutions in managing infectious diseases has gained prominence, reflecting changes in healthcare delivery models during the pandemic. - Innovative Diagnostics and Surveillance Technologies:
Emerging themes include the development and evaluation of novel diagnostic tools and surveillance methodologies for rapid detection of infectious diseases, particularly for outbreaks.
Declining or Waning
- Non-communicable Disease Associations:
The journal's previous emphasis on the intersection of infectious diseases with non-communicable diseases has waned, as the focus has shifted more towards acute infectious disease management and COVID-19-related research. - Traditional Infectious Diseases:
There appears to be a reduction in studies centered on traditional infectious diseases, such as tuberculosis and malaria, in favor of more contemporary issues such as COVID-19 and emerging zoonotic diseases. - Historical Epidemiological Studies:
Research exploring historical data on infectious diseases has decreased, reflecting a shift towards current epidemic responses and real-time data analysis. - Regional Studies of Infectious Diseases:
There has been a noticeable decline in region-specific studies focusing on endemic diseases, as the journal increasingly prioritizes global perspectives and broader public health implications.
Similar Journals
Mediterranean Journal of Infection Microbes and Antimicrobials
Unlocking insights into the realm of infectious microbes.Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.
International Journal of Antimicrobial Agents
Pioneering Insights into Antimicrobial Efficacy and SafetyInternational Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.
EMERGING INFECTIOUS DISEASES
Shaping the Future of Epidemiology and Public HealthEmerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.
Eurosurveillance
Advancing global health through open access research.Eurosurveillance is a prestigious journal dedicated to the field of epidemiology, public health, and infectious diseases, published by the European Centre for Disease Prevention and Control since 1996. With an impressive Q1 ranking across various categories, including Epidemiology and Public Health, it consistently stands at the forefront of research dissemination, making it an invaluable resource for researchers, professionals, and students alike. The journal boasts an outstanding reputation, as evidenced by its Scopus rankings, where it ranks in the top 1% to 3% in multiple relevant categories. As an Open Access publication, Eurosurveillance ensures that vital findings are freely accessible to a global audience, fostering collaboration and innovation in the fight against infectious diseases. With a dedicated reach from 2001 to 2024, the journal addresses contemporary challenges in public health and virology, reinforcing its significance in shaping policies and research initiatives across the world.
Klimik Journal
Catalyzing Discussions in Infectious Disease Science.Klimik Journal is a pivotal publication in the fields of Infectious Diseases and Medical Microbiology, serving as a platform for researchers, clinicians, and academics to disseminate groundbreaking findings and improve health outcomes. Established in 2010 and published by DOC DESIGN INFORMATICS CO LTD, this journal is dedicated to advancing knowledge and fostering discussions around critical issues in infectious diseases and microbial research. With an ISSN of 1301-143X and an E-ISSN of 1309-1484, Klimik Journal strives to maintain high academic standards despite currently ranking in the fourth quartile in both categories according to Scopus metrics, which highlights the need for continued contributions to the field. Operating from Turkey, the journal is committed to supporting open access options, thereby ensuring wide dissemination of research findings. As it continues to bridge the gap between theory and practice, Klimik Journal is poised to become an essential resource for those looking to stay at the forefront of infectious disease research and microbiological advancements.
JOURNAL OF INFECTIOUS DISEASES
Advancing the Frontiers of Infectious Disease ResearchThe JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.
GERMS
Bridging disciplines to combat infectious diseases effectively.GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.
Emerging Microbes & Infections
Elevating global health through open access research.Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.
Journal of Pathogens
Transforming Insights into Actionable KnowledgeJournal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.
Archives of Clinical Infectious Diseases
Pioneering Research for Public Health ImpactArchives of Clinical Infectious Diseases is a peer-reviewed journal dedicated to advancing knowledge in the field of infectious diseases, published by BRIEFLAND in Iran. With a broad scope, it covers various aspects of cardiology, critical care, immunology, microbiology, public health, and toxicology, affirming its relevance in today's health landscape. Despite the lack of open access options, the journal maintains a strong reputation, reflected in its Q3 ranking in multiple categories within the 2023 category quartiles. The journal aims to provide a platform for researchers and practitioners to disseminate critical findings that can impact clinical practices and public health policies. Its commitment to rigorous peer review ensures that only high-quality research is published, thereby serving as an essential resource for professionals, students, and public health advocates. For those engaged in the ever-evolving world of infectious diseases, Archives of Clinical Infectious Diseases stands as a vital contribution to the medical literature.